Companies that own Peptron Inc.
Multi Asset Global Investments Co., Ltd.
903,102
5.89%
903,102
100%
07/31/2018
National Pension Service of Korea
631,010
4.12%
631,010
0.01%
02/12/2018
ARK Impact Asset Management Co., Ltd.
502,000
3.28%
262,000
100%
09/30/2017
The Vanguard Group, Inc.
298,786
1.95%
-18
0%
07/31/2018
Norges Bank Investment Management
37,504
0.25%
21,502
0%
12/31/2017
Mirae Asset Global Investments Co., Ltd.
26,334
0.17%
6,424
0.01%
04/30/2018
Charles Schwab Investment Management, Inc.
21,967
0.14%
0
0%
09/06/2018
SSgA Funds Management, Inc.
14,618
0.1%
0
0%
09/06/2018
BlackRock Advisors (UK) Ltd.
8,784
0.06%
0
0%
09/05/2018
BlackRock Fund Advisors
6,726
0.04%
0
0%
09/05/2018
| Address |
37-24 Yuseong-daero 1628beon-gil
Daejeon DE 34054
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.peptron.co.kr |
| Updated |
09/14/2018 |
| Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative neuronal disease, and obesity, peptide materials, and cosmetics. The company was founded on November 21, 1997 and is headquartered in Daejeon, South Korea. |
